Published in Endoscopy on March 01, 2006
Chromoendoscopy for Serrated Polyposis Syndrome (SERRADA) | NCT03476434
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol (2011) 1.50
Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One (2010) 1.36
Serrated pathway colorectal cancer in the population: genetic consideration. Gut (2007) 1.29
Malignant colorectal polyps. World J Gastroenterol (2010) 1.27
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27
A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol (2011) 1.16
Serrated polyposis syndrome: molecular, pathological and clinical aspects. World J Gastroenterol (2012) 1.03
Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Patholog Res Int (2011) 1.01
Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol (2015) 1.00
Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol (2012) 0.97
Genetic predisposition to colorectal cancer: where we stand and future perspectives. World J Gastroenterol (2014) 0.90
Gastric duodenal metaplasia in duodenal adenomas. J Clin Pathol (2006) 0.87
Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome). Fam Cancer (2011) 0.87
Serrated polyps of right colon: guilty or innocent? Ann Gastroenterol (2013) 0.84
Widespread hyperplasia induced by transgenic TGFalpha in ApcMin mice is associated with only regional effects on tumorigenesis. Carcinogenesis (2008) 0.81
Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer. Future Oncol (2010) 0.78
Prevalence of serrated polyposis syndrome and its association with synchronous advanced adenoma and lifestyle. Mol Clin Oncol (2014) 0.78
Serrated polyposis is an underdiagnosed and unclear syndrome: the surgical pathologist has a role in improving detection. Am J Surg Pathol (2012) 0.77
Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis. Clin Gastroenterol Hepatol (2015) 0.76
Three Colon Adenocarcinomas Arising in a Patient with Serrated Polyposis Syndrome: Case Report and Review of the Literature. Viszeralmedizin (2014) 0.75
The clinical impact of serrated colorectal polyps. Clin Epidemiol (2017) 0.75
Clinical characteristics of patients with serrated polyposis syndrome in Korea: comparison with Western patients. Intest Res (2017) 0.75
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ (2009) 3.62
Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis (2004) 2.87
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest (1998) 2.27
Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol (1996) 1.88
Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat (1997) 1.88
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A (2001) 1.80
Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis (2001) 1.80
A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer (1998) 1.79
Immune mechanisms in atherosclerosis. Arteriosclerosis (1989) 1.78
Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res (2001) 1.70
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant (2010) 1.59
Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis (1988) 1.57
Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol Biol Cell (1994) 1.56
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
The social determinants of health: key to global tuberculosis control. Int J Tuberc Lung Dis (2011) 1.44
Reduced frequency of memory CD8+ T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis. Autoimmunity (1995) 1.39
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut (2002) 1.38
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis (2001) 1.36
Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects. Int J Tuberc Lung Dis (2011) 1.35
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer (1995) 1.34
Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol (2001) 1.32
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics (1998) 1.30
Localization of ribonucleotide reductase in mammalian cells. EMBO J (1984) 1.30
Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis (2011) 1.30
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia (2013) 1.27
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res (2001) 1.20
Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest (2001) 1.19
Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet (2006) 1.18
Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res (1995) 1.17
Maxillary sinusitis caused by Schizophyllum commune and experience with treatment. J Med Vet Mycol (1998) 1.17
Anticholinergic medication in diagnostic endoscopy of the upper gastrointestinal tract. Endoscopy (1991) 1.16
Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum (2002) 1.14
Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test (1999) 1.14
The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res (1998) 1.14
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res (1998) 1.12
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer (2010) 1.11
Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. Haemophilia (2013) 1.11
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet (2008) 1.11
A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet (1998) 1.10
COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer (2001) 1.10
High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer. J Med Genet (2005) 1.10
Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test (2005) 1.10
ATM mutations in cancer families. Cancer Res (1996) 1.09
Oral sedation for diagnostic upper endoscopy. Endoscopy (1991) 1.08
Identification and analysis of macrophage-derived foam cells from human atherosclerotic lesions by using a "mock" FL3 channel in flow cytometry. Cytometry (1997) 1.07
MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res (2001) 1.06
Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut (2003) 1.06
Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet (1997) 1.06
Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? Endoscopy (2005) 1.05
A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med (2001) 1.04
Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer (2000) 1.04
Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res (2001) 1.04
Classification of colorectal polyps: guidelines for the endoscopist. Endoscopy (2002) 1.03
Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet (2004) 1.03
Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer (2000) 1.01
The macrophage scavenger receptor type A directs modified proteins to antigen presentation. Eur J Immunol (1999) 1.01
Expression of interleukin-15 in mouse and human atherosclerotic lesions. Am J Pathol (2001) 1.00
Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon. Gastroenterology (2001) 1.00
Ki-ras mutations and prognosis in colorectal cancer. Eur J Cancer (1998) 0.99
Hereditary breast cancer: a review. Semin Cancer Biol (2000) 0.99
Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol (1993) 0.98
Tuberculosis and poverty: what is being done. Int J Tuberc Lung Dis (2011) 0.98
Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol (1995) 0.97
Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet (1999) 0.97
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer (2014) 0.96
Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol (1995) 0.96
Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. J Clin Oncol (2004) 0.95
Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves. Acta Physiol Scand (1986) 0.94
Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas. Genes Chromosomes Cancer (2000) 0.92
Calcium binding to tandem repeats of EGF-like modules. Expression and characterization of the EGF-like modules of human Notch-1 implicated in receptor-ligand interactions. Protein Sci (1997) 0.91
DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum (1994) 0.91
Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p. Clin Genet (2000) 0.90
TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk. Br J Cancer (2009) 0.90
TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer. Br J Cancer (2007) 0.90
Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients. J Clin Virol (2008) 0.89
Clinical spectral characterisation of colonic mucosal lesions using autofluorescence and delta aminolevulinic acid sensitisation. Gut (1999) 0.89
T-cell recognition of lipid peroxidation products breaks tolerance to self proteins. Immunology (1999) 0.88
A human compound heterozygote for two MLH1 missense mutations. Nat Genet (1997) 0.87
Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Anticancer Res (2001) 0.87
Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden. Euro Surveill (2013) 0.87
Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours. Br J Cancer (1999) 0.87
Non-polypoid adenomas of the colon are associated with subjacent lymphoid nodules. An experimental study in rats. Scand J Gastroenterol (1999) 0.85
Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22-p21 tumour-suppressor region by two-colour fluorescence in situ hybridization. Chromosome Res (1996) 0.85
Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve. Brain Res (1985) 0.85
BRCA2 germline mutations in Swedish breast cancer families. Eur J Hum Genet (1998) 0.84